Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single-center experience

被引：0
|
作者：
Colussi, Lara [1 ]
Dagri, Arianna [2 ]
Pastore, Serena [3 ]
Tommasini, Alberto [1 ,3 ]
Pin, Alessia [3 ]
Taddio, Andrea [1 ,3 ]
机构：
[1] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy
[2] Univ Udine, Dept Med DAME, Div Pediat, Udine, Italy
[3] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2024年 / 27卷 / 08期
关键词：
LOCALIZED SCLERODERMA;
D O I：
10.1111/1756-185X.15295
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Janus Kinase Inhibitor Tofacitinib for Induction and Remission in ulcerative colitis
    Sandborn, W. J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (14) : 1022 - 1023
  • [22] Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
    Sandborn, William J.
    Ghosh, Subrata
    Panes, Julian
    Vranic, Ivana
    Su, Chinyu
    Rousell, Samantha
    Niezychowski, Wojciech
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (07): : 616 - 624
  • [23] Tofacitinib: A novel oral Janus kinase inhibitor for rheumatoid arthritis
    O'Dell, Kate M.
    Rummel, Ashley E.
    FORMULARY, 2012, 47 (10) : 350 - +
  • [24] Single-center experience with rituximab in the treatment of inhibitor-associated hemostatic disorders
    Hammond, D.
    Saidenberg, E.
    Tinmouth, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 762 - 762
  • [25] Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of Tofacitinib, a Janus Kinase Inhibitor, in Healthy Volunteers
    Krishnaswami, Sriram
    Boy, Mary
    Chow, Vincent
    Chan, Gary
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (02): : 83 - 88
  • [26] Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review
    Ibrahim, O.
    Hogan, S.
    Piliang, M.
    Bergfeld, W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S65 - S65
  • [27] Long-term safety data for tofacitinib, an oral Janus kinase inhibitor, for the treatment for psoriasis
    Lloyd-Lavery, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 815 - 816
  • [28] Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience
    Pardeo, Manuela
    Marafon, Denise Pires
    Insalaco, Antonella
    Bracaglia, Claudia
    Nicolai, Rebecca
    Messia, Virginia
    De Benedetti, Fabrizio
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (08) : 1523 - 1527
  • [29] DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH JUVENILE SCLERODERMA-A SINGLE CENTER EXPERIENCE
    Adrovic, A.
    Sahin, S.
    Barut, K.
    Koka, A.
    Kasapcopur, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 269 - 269
  • [30] Renal Biopsy in Children—Effect on Treatment Decisions: A Single-Center Experience
    Rakesh Kumar Pilania
    G. V. Venkatesh
    Ritambhra Nada
    Pandiarajan Vignesh
    Ankur Kumar Jindal
    Deepti Suri
    Karalanglin Tiewsoh
    Indian Journal of Pediatrics, 2021, 88 : 1036 - 1039
12345